Primary, Boral, Inghams and Sonic - First impressions from reporting

Bell Potter

Stockbroker

(VIEW LINK)


Boral: Net operating cash flow up 39.7% to $158m Divisional EBIT: Boral Australia (66% of rev) EBIT down 3% to $164m; USG Boral (15% of rev) up 28% to $117m; Boral USA (19% of rev) $13m. | Outlook: Boral’s outlook for FY2017 remains largely unchanged, with Boral’s EBIT expected to be higher than the EBIT delivered in FY2016, with improved performance partially offset by the loss of EBIT of ~$6.5 million associated with the divestment of Boral’s 40% share of Boral CSR Bricks in Nov-16.  (VIEW LINK)


Sonic Healthcare: Net operating cash flow up 2.6% to $333.2m | Constant currency revenue growth was 5%, driven mainly by growth in Germany 6% and Switzerland 8%; the UK- 3% and Belgium (flat) experienced a slowdown. Australian Pathology grew 7% (4% was organic). Organic cc growth in US Pathology was 3.3%. Imaging organic growth was 4%. | Outlook: Sonic guided to FY17 CC EBITDA growth of 5% +.  (VIEW LINK)


Inghams Group: EBIT up 8.6% to $76.9m and EBIT margin 6.3% | Net operating cash flow up 11% to $79.2m | Outlook: “The company reconfirms that its FY17 prospectus forecast of $98.8M pro forma NPAT is expected to be achieved based on the current trading outlook. Reconfirm intention to pay fully franked dividends of 65 – 70% of pro forma NPAT.”:    (VIEW LINK)


Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.